Select Medical Holdings (SEM)

Gross profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit (ttm) US$ in thousands 475,493 846,758 882,765 926,010 932,041 892,943 843,735 787,001 733,377 717,946 780,508 858,889 919,366 976,025 982,404 860,094 821,341 806,376 773,690 834,642
Revenue (ttm) US$ in thousands 5,187,103 6,968,550 6,873,020 6,787,890 6,664,060 6,586,660 6,488,760 6,398,970 6,333,540 6,311,890 6,278,320 6,257,600 6,204,510 6,105,190 5,994,840 5,663,540 5,531,710 5,445,800 5,415,270 5,543,910
Gross profit margin 9.17% 12.15% 12.84% 13.64% 13.99% 13.56% 13.00% 12.30% 11.58% 11.37% 12.43% 13.73% 14.82% 15.99% 16.39% 15.19% 14.85% 14.81% 14.29% 15.06%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $475,493K ÷ $5,187,103K
= 9.17%

The gross profit margin of Select Medical Holdings has shown fluctuations over the reported periods. It started at 15.06% in March 2020 and experienced marginal changes until June 2021, where it peaked at 16.39%. However, in the subsequent quarters, the gross profit margin declined gradually to 9.17% by December 2024.

The declining trend observed after June 2021 could indicate challenges in managing production costs, pricing strategies, or competitive pressures. This decrease in gross profit margin may raise concerns about the company's ability to maintain profitability and efficiently manage its cost structure.

Management should closely monitor the trends in gross profit margin, identify the underlying factors contributing to the decline, and implement strategies to improve operational efficiency and cost control to ensure sustainable profitability in the long term.


Peer comparison

Dec 31, 2024

Company name
Symbol
Gross profit margin
Select Medical Holdings
SEM
9.17%
Encompass Health Corp
EHC
29.30%
Mednax Inc
MD
21.62%